Cero Therapeutics Holdings, Inc.
CERO- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001870404
No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesCEROW
Q2 2023 vs. Q1 2023
How the institutions holding Cero Therapeutics Holdings, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 17 | 13 | −4 |
| Shares | 1.33M | 1.13M | −197.7K (−14.9%) |
| Value | $12.5M | $10.6M | −$1.93M (−15.4%) |
New holders (2)
Institutions that held Cero Therapeutics Holdings, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Yakira Capital Management, Inc. | 108,103 | $1.18M | 0.31% |
| FNY Investment Advisers, LLC | 2,084 | $22.0K | 0.03% |
Sold out (6)
Institutions that held Cero Therapeutics Holdings, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Periscope Capital Inc. | 149,300 | $1.59M |
| Kim, LLC | 100,000 | $1.07M |
| Shaolin Capital Management LLC | 97,000 | $1.04M |
| Boothbay Fund Management, LLC | 49,587 | $529.6K |
| Gritstone Asset Management LLC | 34,026 | $363.4K |
| Susquehanna International Group, LLP | 13,571 | $144.9K |